NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid

Hepatology Communications
Kathy L de GraafPietro Invernizzi

Abstract

NI-0801 is a fully human monoclonal antibody against chemokine (C-X-C motif) ligand 10 (CXCL10), which is involved in the recruitment of inflammatory T cells into the liver. The safety and efficacy of NI-0801 was assessed in patients with primary biliary cholangitis. In this open-label phase 2a study, patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid received six consecutive intravenous administrations of NI-0801 (10 mg/kg) every 2 weeks. Patients were followed up for 3 months after the last infusion. Liver function tests, safety assessments, as well as pharmacokinetic and pharmacodynamic parameters were evaluated at different time points throughout the dosing period and the safety follow-up period. Twenty-nine patients were enrolled in the study and were treated with NI-0801. The most frequently reported adverse events included headaches (52%), pruritus (34%), fatigue (24%), and diarrhea (21%). No study drug-related serious adverse events were reported. NI-0801 administration did not lead to a significant reduction in any of the liver function tests assessed at the end of the treatment period (i.e., 2 weeks after final NI-0801 administration) compared to baseline. Conclusion: Despite...Continue Reading

References

Nov 21, 1998·Gut·K Cauch-DudekE J Heathcote
Dec 12, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A SautyA D Luster
Aug 30, 2005·The American Journal of Pathology·Stuart M CurbishleyDavid H Adams
Sep 24, 2005·The New England Journal of Medicine·Marshall M Kaplan, M Eric Gershwin
Oct 29, 2005·Journal of Hepatology·Nora V Bergasa
May 24, 2007·Seminars in Liver Disease·Pietro InvernizziMauro Podda
Dec 19, 2007·Medical Molecular Morphology·Hiroyuki YoneyamaTakafumi Ichida
May 6, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrea MeiserJames E Pease
Sep 18, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marija ZeremskiAndrew H Talal
May 18, 2010·Journal of Hepatology·Christophe CorpechotRaoul Poupon
Oct 12, 2010·Journal of Autoimmunity·Edith HintermannUrs Christen
Jan 12, 2011·Immunology and Cell Biology·Joanna R Groom, Andrew D Luster
May 13, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Pietro Invernizzi
Jun 8, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Frank TackeHermann E Wasmuth
Jun 8, 2011·Clinical & Developmental Immunology·Wen ZhangFengchun Zhang
Aug 30, 2011·BMC Gastroenterology·Fumi K VaryaniTimothy R Card
May 9, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ulrich BeuersRonald P J Oude Elferink
Jul 25, 2014·Seminars in Liver Disease·Pietro Invernizzi
Jul 25, 2014·Seminars in Liver Disease·Ilaria BianchiPietro Invernizzi
Sep 20, 2015·Journal of Hepatology·Ulrich BeuersRaoul Poupon
Dec 8, 2015·Digestive Diseases·Laura Jopson, David E J Jones
Apr 22, 2017·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, UNKNOWN European Association for the Study of the Liver

❮ Previous
Next ❯

Citations

Apr 11, 2019·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Atsushi Tanaka
Jun 6, 2019·Nature Reviews. Gastroenterology & Hepatology·Luca FabrisMario Strazzabosco
Feb 28, 2020·Expert Opinion on Investigational Drugs·Christopher ChangM Eric Gershwin
Dec 22, 2019·The Journal of Clinical Endocrinology and Metabolism·Poupak FallahiAlessandro Antonelli
Aug 7, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Domenico AlvaroPietro Invernizzi
Mar 21, 2019·Clinical Science·Wen-Tao Ma, De-Kun Chen
Nov 13, 2019·Clinical Reviews in Allergy & Immunology·Lixia GaoM Eric Gershwin
Apr 2, 2019·Expert Opinion on Pharmacotherapy·Andrea A Gossard, Keith D Lindor
Dec 1, 2020·Expert Opinion on Investigational Drugs·Eric M Gochanour, Kris V Kowdley
Dec 15, 2020·Lancet·Ana LleoGideon M Hirschfield
Dec 29, 2020·Journal of Experimental Pharmacology·Annarosa Floreani
Apr 22, 2021·Journal of Hepatology·Atsushi TanakaChristophe Corpechot
May 4, 2021·Frontiers in Immunology·Tamsin Cargill, Emma L Culver
May 13, 2021·Nature Reviews. Gastroenterology & Hepatology·Sheng CaoVijay H Shah
Jul 28, 2020·Journal of Hepatology·Marco CarbonePietro Invernizzi
Jun 16, 2021·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ben Barron-MillarDavid E J Jones

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
enzyme‐linked immunosorbent assay
flow cytometry

Clinical Trials Mentioned

NCT01430429

Software Mentioned

SAS
GraphPad
GraphPad Prism

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.